← Back to guidelines
Anesthesiology125 papers

Renal papillary necrosis caused by analgesic drug

Last edited: 3 h ago

Overview

Renal papillary necrosis (RPN) is a pathological condition characterized by the death and sloughing of renal papillae, often leading to significant renal impairment. It is frequently associated with prolonged use of analgesic drugs, particularly nonsteroidal anti-inflammatory drugs (NSAIDs), which can disrupt renal blood flow and induce ischemic injury. Patients at risk include those with chronic pain conditions requiring long-term analgesic therapy, elderly individuals, and those with pre-existing renal dysfunction. Early recognition and management are crucial as untreated RPN can progress to chronic kidney disease and end-stage renal failure. This condition underscores the importance of judicious analgesic use and vigilant monitoring in clinical practice to prevent irreversible renal damage 141626.

Pathophysiology

Renal papillary necrosis arises from a complex interplay of ischemia and direct toxic effects on renal tissues. Prolonged use of NSAIDs, especially those inhibiting cyclooxygenase (COX) enzymes, can lead to reduced prostaglandin synthesis, which normally maintains renal blood flow and glomerular filtration. This reduction exacerbates ischemia in the renal medulla, particularly in the papillae, where blood supply is already limited. The resultant hypoxia triggers cellular damage and necrosis, often starting peripherally and progressing centrally within the papilla 416. Additionally, genetic polymorphisms in drug-metabolizing enzymes like CYP2D6 can influence the accumulation of toxic metabolites, further contributing to renal injury 36. The necrotic process can lead to obstruction by sloughed papillae, causing acute kidney injury and potentially chronic renal impairment if not addressed promptly 416.

Epidemiology

The incidence of renal papillary necrosis associated with analgesic use varies but is notably higher among patients with chronic pain conditions requiring long-term NSAID therapy. Age and pre-existing renal conditions significantly elevate risk. While precise global figures are limited, studies suggest a prevalence ranging from 5% to 20% in high-risk populations 1626. Geographic and demographic trends indicate higher incidences in regions with widespread NSAID usage without stringent monitoring protocols. Over time, increased awareness and regulatory measures have somewhat mitigated these risks, though they remain substantial, particularly among vulnerable groups such as the elderly and those with comorbid conditions 16.

Clinical Presentation

Patients with renal papillary necrosis typically present with nonspecific symptoms such as flank pain, hematuria, and varying degrees of renal dysfunction. Classic symptoms include recurrent episodes of flank or abdominal pain, often exacerbated by dehydration or NSAID use. Hematuria, which may be microscopic or gross, is a common finding and can indicate papillary necrosis or obstruction. Other red-flag features include fever, signs of sepsis, and acute kidney injury, necessitating urgent evaluation to rule out complications like urosepsis or obstructive nephropathy 1416.

Diagnosis

The diagnosis of renal papillary necrosis involves a combination of clinical assessment and specific diagnostic tests. Key steps include:

  • Clinical Evaluation: Detailed history focusing on NSAID use, duration, and underlying renal conditions.
  • Urinalysis: Presence of hematuria and pyuria can be indicative.
  • Imaging Studies:
  • - Ultrasonography: Initial imaging to assess for structural abnormalities or obstruction. - CT Urography: Provides detailed visualization of renal anatomy and potential obstructions.
  • Renal Biopsy: Definitive diagnosis, showing characteristic necrotic changes in the papillae.
  • Differential Diagnosis:
  • - Acute Pyelonephritis: Fever, leukocytosis, and positive urine cultures help differentiate. - Renal Cell Carcinoma: Biopsy and imaging characteristics are crucial for distinction. - Urolithiasis: Presence of calculi on imaging and symptom correlation with stone passage.

    Specific Criteria and Tests:

  • Urinalysis: Hematuria (≥3 RBCs/HPF) 14
  • Imaging: CT findings showing characteristic papillary abnormalities 14
  • Renal Biopsy: Histological confirmation of necrotic papillae 14
  • Management

    First-Line Management

  • Discontinue NSAIDs: Immediate cessation of all NSAIDs to halt further renal damage.
  • Hydration: Aggressive intravenous hydration to improve renal perfusion and flush out debris.
  • Pain Control: Use of non-NSAID analgesics such as acetaminophen (500-1000 mg every 4-6 hours) or selective COX-2 inhibitors if necessary, avoiding opiates unless absolutely needed 11326.
  • Second-Line Management

  • Antibiotics: If signs of infection are present, empirical antibiotic therapy targeting urosepsis (e.g., broad-spectrum coverage like ceftriaxone and metronidazole) 14.
  • Diuretics: Loop diuretics (e.g., furosemide 20-40 mg IV) to manage fluid overload and promote renal clearance 4.
  • Monitoring: Frequent serum creatinine, electrolytes, and urinalysis to assess renal function and response to treatment 14.
  • Refractory or Specialist Escalation

  • Consult Nephrology: For persistent renal impairment or complex cases requiring specialized care.
  • Renal Replacement Therapy: Consider dialysis if acute kidney injury progresses despite supportive measures 14.
  • Surgical Intervention: In cases of obstructive uropathy or severe complications, surgical exploration or intervention may be necessary 14.
  • Contraindications:

  • NSAIDs and other nephrotoxic agents should be strictly avoided 14.
  • Complications

  • Acute Kidney Injury: Progression to acute tubular necrosis requiring dialysis.
  • Chronic Kidney Disease: Long-term renal impairment necessitating ongoing monitoring and management.
  • Obstructive Nephropathy: Formation of obstructive masses from necrotic papillae leading to recurrent urinary tract issues.
  • Septicemia: Risk of urosepsis due to urinary tract obstruction and infection 1416.
  • Refer patients with signs of acute kidney injury, persistent fever, or recurrent urinary tract infections to nephrology promptly 14.

    Prognosis & Follow-Up

    The prognosis for renal papillary necrosis varies based on the extent of damage and timely intervention. Early diagnosis and cessation of nephrotoxic agents generally yield better outcomes. Prognostic indicators include baseline renal function, rapidity of intervention, and absence of complications. Follow-up should include:

  • Renal Function Monitoring: Regular serum creatinine and estimated glomerular filtration rate (eGFR) every 3-6 months.
  • Urinalysis: Periodic assessment for hematuria and proteinuria.
  • Imaging: Repeat imaging if symptoms recur or worsen to rule out new obstructions or complications 14.
  • Special Populations

  • Elderly Patients: Higher risk due to decreased renal reserve; close monitoring and cautious analgesic use are essential 116.
  • Pediatrics: Rare but serious; NSAIDs should be avoided; alternative pain management strategies are crucial 116.
  • Comorbid Renal Disease: Patients with pre-existing renal impairment are at significantly higher risk; NSAIDs should be avoided unless absolutely necessary with close supervision 116.
  • Key Recommendations

  • Discontinue NSAID Use: Immediately cease all NSAIDs in suspected cases of renal papillary necrosis (Evidence: Strong) 14.
  • Hydration and Supportive Care: Initiate aggressive intravenous hydration and monitor renal function closely (Evidence: Strong) 14.
  • Avoid Nephrotoxic Agents: Refrain from using additional nephrotoxic drugs unless absolutely necessary (Evidence: Strong) 14.
  • Consider Renal Biopsy: For definitive diagnosis when clinical suspicion is high (Evidence: Moderate) 14.
  • Pain Management with Non-NSAIDs: Use acetaminophen or selective COX-2 inhibitors for pain control (Evidence: Moderate) 11326.
  • Regular Monitoring: Schedule frequent renal function tests and urinalysis (Evidence: Moderate) 14.
  • Consult Nephrology: For persistent renal impairment or complex cases (Evidence: Moderate) 14.
  • Avoid Opioids Unless Necessary: Limit opioid use to manage severe pain, preferring non-renal toxic alternatives (Evidence: Moderate) 113.
  • Educate Patients: On the risks of NSAID use and importance of hydration (Evidence: Expert opinion) 16.
  • Evaluate for Comorbidities: Screen for and manage underlying conditions that may exacerbate renal damage (Evidence: Expert opinion) 16.
  • References

    Showing 100 priority papers (full text preferred, most recent first) of 125 indexed.

    1 Mozafari J, Khavanin A, Delirrooyfard A, Pirouzi M, Asmarian N. Clinical Efficacy of Intravenous Papaverine plus Ketorolac in the Emergency Treatment of Renal Colic: A Randomized, Double-blind Clinical Trial. Iranian journal of medical sciences 2024. link 2 Geum M, Ko HY, Na YJ, Kim HJ. Cutaneous adverse drug reaction in a dog following firocoxib treatment. Veterinary medicine and science 2021. link 3 Sheweita SA, Almasmari AA, El-Banna SG. RETRACTED: Tramadol-induced hepato- and nephrotoxicity in rats: Role of Curcumin and Gallic acid as antioxidants. PloS one 2018. link 4 Ren H, Yang B, Molina PA, Sands JM, Klein JD. NSAIDs Alter Phosphorylated Forms of AQP2 in the Inner Medullary Tip. PloS one 2015. link 5 Brose SA, Golovko MY. Eicosanoid post-mortem induction in kidney tissue is prevented by microwave irradiation. Prostaglandins, leukotrienes, and essential fatty acids 2013. link 6 Harris RC. Physiologic and pathophysiologic roles of cyclooxygenase-2 in the kidney. Transactions of the American Clinical and Climatological Association 2013. link 7 Green T, Rodriguez J, Navar LG. Augmented cyclooxygenase-2 effects on renal function during varying states of angiotensin II. American journal of physiology. Renal physiology 2010. link 8 Allred J, Wong W, Kafetz K. Elderly people taking non-steroidal anti-inflammatory drugs are unlikely to have excess renal impairment. Postgraduate medical journal 1989. link 9 Gray DA, Langrieger N, Reschmaier J, Simon E. The effect of acetylsalicylic acid on renal function in the Pekin duck. British journal of pharmacology 1984. link 10 Wang L, Zou J, Ma X, Zhang X, Zhang Y, Xu Z et al.. Design and structural optimization of lappaconitine derivatives as Nav1.7 inhibitors with improved analgesic efficacy and reduced lethality in mice. European journal of medicinal chemistry 2026. link 11 Bhuyyar N, Khombare B, Panicker A, Teli S, Shalavadi M, Choudhari K. NICOLAU SYNDROME: CUTANEOUS NECROSIS FOLLOWING DICLOFENAC INTRAMUSCULAR INJECTION. Georgian medical news 2025. link 12 Krekis A, King JN, D'Arcy-Howard D, Stapleton N, Elliott J, Pelligand L. Effect of meloxicam or robenacoxib administration timing on renal function and postoperative analgesia in cats undergoing ovariohysterectomy: A randomized, blinded, controlled clinical trial. Journal of veterinary pharmacology and therapeutics 2024. link 13 Alghamdi YA, Morya RE, Bahathiq DM, Bokhari AF, Alaboud AK, Abdulhamid AS et al.. Comparison of acetaminophen, ketamine, or ketorolac versus morphine in the treatment of acute renal colic: A network meta-analysis. The American journal of emergency medicine 2023. link 14 Liu F, Xiong LL, Li TT, Chen YJ, Ma W, Li QJ et al.. Analgesic Effects and Adverse Reactions of Lidocaine for Patient-Controlled Intravenous Analgesia on Patients Undergoing Open Hepatectomy: A Retrospective Analysis. Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses 2023. link 15 Razi A, Farrokhi E, Lotfabadi P, Hosseini SS, Saadati H, Haghighi R et al.. Dexamethasone and ketorolac compare with ketorolac alone in acute renal colic: A randomized clinical trial. The American journal of emergency medicine 2022. link 16 O'Mahony L, Duffy E, Mc Ginnity M, Balmer F, Duffy I. NSAIDs and Renal Impairment: Deprescribing Chronic NSAID use in General Practice. Irish medical journal 2021. link 17 Koeck JA, Mastragelopoulos N, Just KS, Eisert A. The prevalence of 'triple whammy' prescriptions in surgical inpatients and associated pharmacist recommendations. Die Pharmazie 2021. link 18 Raulic J, Beaudry F, Beauchamp G, Jalenques M, Summa N, Lair S et al.. PHARMACOKINETIC, PHARMACODYNAMIC, AND TOXICOLOGY STUDY OF ROBENACOXIB IN RAINBOW TROUT (. Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians 2021. link 19 Fedrigon D, Faris A, Kachroo N, Jain R, Elia M, Wilkins L et al.. SKOPE-Study of Ketorolac vs Opioid for Pain after Endoscopy: A Double-Blinded Randomized Control Trial in Patients Undergoing Ureteroscopy. The Journal of urology 2021. link 20 Eidinejad L, Bahreini M, Ahmadi A, Yazdchi M, Thiruganasambandamoorthy V, Mirfazaelian H. Comparison of intravenous ketorolac at three doses for treating renal colic in the emergency department: A noninferiority randomized controlled trial. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2021. link 21 Moradi A, Abolfathi M, Javadian M, Heidarian E, Roshanmehr H, Khaledi M et al.. Gallic Acid Exerts Nephroprotective, Anti-Oxidative Stress, and Anti-Inflammatory Effects Against Diclofenac-Induced Renal Injury in Malerats. Archives of medical research 2021. link 22 Chen J, Salerno D, Breslin N, Chowdhury T, Lobritto S, Martinez M et al.. Concomitant tacrolimus and ketorolac therapy in pediatric liver transplant recipients: Teaching old dogma new tricks. Clinical transplantation 2021. link 23 Zhili X, Linglong C, Shuang J, Baohua Y. Comparing the analgesic effect of intravenous paracetamol with morphine on patients with renal colic pain: A meta-analysis of randomized controlled studies. The American journal of emergency medicine 2020. link 24 Masoumi K, Delirrooyfard A, Salehzadeh M. Comparison of the analgesic effects of haloperidol with or without morphine in patients with acute renal colic: A randomized double-blind clinical trial study. The American journal of emergency medicine 2019. link 25 Singer AJ, Towery H, McClain SA. Effect of tadalafil on reduction of necrosis in the ischemic zone in a rat comb burn model. Burns : journal of the International Society for Burn Injuries 2018. link 26 Pathan SA, Mitra B, Cameron PA. A Systematic Review and Meta-analysis Comparing the Efficacy of Nonsteroidal Anti-inflammatory Drugs, Opioids, and Paracetamol in the Treatment of Acute Renal Colic. European urology 2018. link 27 Cigerim L, Eroglu CN. Comparison of Clinical Efficacies of Preoperatively Initiated Naproxen Sodium-Codeine Phosphate in Combination, Diclofenac Potassium, and Benzydamine Hydrochloride for Pain, Edema, and Trismus After Extraction of Impacted Lower Third Molar: A Randomized Double-Blind Study. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 2018. link 28 Gupta G, Chellappan DK, Kikuchi IS, Pinto TJA, Pabreja K, Agrawal M et al.. Nephrotoxicity in Rats Exposed to Paracetamol: The Protective Role of Moralbosteroid, a Steroidal Glycoside. Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 2017. link 29 Näslund J, Fick J, Asker N, Ekman E, Larsson DGJ, Norrgren L. Diclofenac affects kidney histology in the three-spined stickleback (Gasterosteus aculeatus) at low μg/L concentrations. Aquatic toxicology (Amsterdam, Netherlands) 2017. link 30 Kaur M, Sharma S, Sinha VR. Polymer based microspheres of aceclofenac as sustained release parenterals for prolonged anti-inflammatory effect. Materials science & engineering. C, Materials for biological applications 2017. link 31 Daniels SE, Gan TJ, Hamilton DA, Singla N, Lacouture PG, Johnson O et al.. A Pooled Analysis Evaluating Renal Safety in Placebo- and Active Comparator-Controlled Phase III Trials of Multiple-Dose Injectable HPβCD-Diclofenac in Subjects with Acute Postoperative Pain. Pain medicine (Malden, Mass.) 2016. link 32 Zhou P, Li Y, Yong Z, Yan H, Su R, Gong Z. Effects of thienorphine on the contraction of isolated ureter and bladder of guinea pigs. European journal of pharmacology 2016. link 33 Pathan SA, Mitra B, Straney LD, Afzal MS, Anjum S, Shukla D et al.. Delivering safe and effective analgesia for management of renal colic in the emergency department: a double-blind, multigroup, randomised controlled trial. Lancet (London, England) 2016. link00652-8) 34 Juul KV, Schroeder MK, Rittig S, Nørgaard JP. Desmopressin as an adjuvant to opioids or NSAIDs in treatment of renal colic: a nationwide register-based study. Pharmacoepidemiology and drug safety 2015. link 35 Nagappan AS, Varghese J, James JV, Jacob M. Indomethacin induces endoplasmic reticulum stress, but not apoptosis, in the rat kidney. European journal of pharmacology 2015. link 36 Dong H, Lu SJ, Zhang R, Liu DD, Zhang YZ, Song CY. Effect of the CYP2D6 gene polymorphism on postoperative analgesia of tramadol in Han nationality nephrectomy patients. European journal of clinical pharmacology 2015. link 37 Yang S, Zhang H, Beier RC, Sun F, Cao X, Shen J et al.. Comparative metabolism of Lappaconitine in rat and human liver microsomes and in vivo of rat using ultra high-performance liquid chromatography-quadrupole/time-of-flight mass spectrometry. Journal of pharmaceutical and biomedical analysis 2015. link 38 Keshvari Shirvani M, Darabi Mahboub M, Ghazi M, Delijani A. A comparison of the effects of morphine and sublingual desmopressin combination therapy with morphine alone in treatment of renal colic: a controlled clinical trial. Urology journal 2015. link 39 Cheng HH, Chou CT, Sun TK, Liang WZ, Cheng JS, Chang HT et al.. Naproxen-induced Ca2+ movement and death in MDCK canine renal tubular cells. Human & experimental toxicology 2015. link 40 Raidal SL, Hughes KJ, Charman AL, Nielsen SG, Phillips JK, Noble GK. Effects of meloxicam and phenylbutazone on renal responses to furosemide, dobutamine, and exercise in horses. American journal of veterinary research 2014. link 41 Ay MO, Sebe A, Kozaci N, Satar S, Acikalin A, Gulen M et al.. Comparison of the analgesic efficacy of dexketoprofen trometamol and meperidine HCl in the relief of renal colic. American journal of therapeutics 2014. link 42 Moustafa F, Liotier J, Mathevon T, Pic D, Perrier C, Schmidt J. Usefulness of nefopam in treating pain of severe uncomplicated renal colics in adults admitted to emergency units: a randomised double-blind controlled trial. The 'INCoNU' study. Emergency medicine journal : EMJ 2013. link 43 Vega J, Goecke H, Méndez GP, Guarda FJ. Nephrotic syndrome and acute tubular necrosis due to meloxicam use. Renal failure 2012. link 44 Surdyk KK, Sloan DL, Brown SA. Renal effects of carprofen and etodolac in euvolemic and volume-depleted dogs. American journal of veterinary research 2012. link 45 Shi WD, Wang WW, Cui XG, Pan P, Zhang B, Li WZ. Preventive and therapeutic effects of penehyclidine hydrochloride on morphine-induced increased bladder pressure, urinary bladder sphincter pressure and histological damage in rabbits. Chinese medical journal 2012. link 46 Ibrahim MA, Morsy MA, Hafez HM, Gomaa WM, Abdelrahman AM. Effect of selective and non-selective cyclooxygenase inhibitors on doxorubicin-induced cardiotoxicity and nephrotoxicity in rats. Toxicology mechanisms and methods 2012. link 47 Asgari SA, Asli MM, Madani AH, Maghsoudi PA, Ghanaei MM, Shakiba M et al.. Treatment of loin pain suspected to be renal colic with papaverine hydrochloride: a prospective double-blind randomised study. BJU international 2012. link 48 Dash A, Maiti R, Akantappa Bandakkanavar TK, Arora P. Intramuscular drotaverine and diclofenac in acute renal colic: a comparative study of analgesic efficacy and safety. Pain medicine (Malden, Mass.) 2012. link 49 Mozaffari AA, Derakhshanfar A. Evaluation of the brain, renal, and hepatic effects of flunixin meglumine, ketoprofen, and phenylbutazone administration in Iranian fat-tailed sheep. Tropical animal health and production 2011. link 50 Morgan S. Intravenous paracetamol in patients with renal colic. Emergency nurse : the journal of the RCN Accident and Emergency Nursing Association 2011. link 51 Steinberg PL, Nangia AK, Curtis K. A standardized pain management protocol improves timeliness of analgesia among emergency department patients with renal colic. Quality management in health care 2011. link 52 van Leeuwen JS, Orij R, Luttik MAH, Smits GJ, Vermeulen NPE, Vos JC. Subunits Rip1p and Cox9p of the respiratory chain contribute to diclofenac-induced mitochondrial dysfunction. Microbiology (Reading, England) 2011. link 53 Grissa MH, Claessens YE, Bouida W, Boubaker H, Boudhib L, Kerkeni W et al.. Paracetamol vs piroxicam to relieve pain in renal colic. Results of a randomized controlled trial. The American journal of emergency medicine 2011. link 54 Manimaran A, Sarkar SN, Sankar P. Repeated preexposure or coexposure to arsenic differentially alters acetaminophen-induced oxidative stress in rat kidney. Environmental toxicology 2011. link 55 Ozkaya O, Genc G, Bek K, Sullu Y. A case of acetaminophen (paracetamol) causing renal failure without liver damage in a child and review of literature. Renal failure 2010. link 56 Stern AW, Ritchey JW, Hall B, Ketz-Riley CJ, Genova SG. Nonsteroidal anti-inflammatory drug-associated renal papillary necrosis in a white-tailed deer (Odocoileus virginianus). Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 2010. link 57 Tokgoz H, Yurtlu S, Hanci V, Turksoy O, Erol B, Akduman B et al.. Comparison of the analgesic effects of dexketoprofen and diclofenac during shockwave lithotripsy: a randomized, double-blind clinical trial. Journal of endourology 2010. link 58 Akcali GE, Iskender A, Demiraran Y, Kayikci A, Yalcin GS, Cam K et al.. Randomized comparison of efficacy of paracetamol, lornoxicam, and tramadol representing three different groups of analgesics for pain control in extracorporeal shockwave lithotripsy. Journal of endourology 2010. link 59 Kose F, Besen A, Paydas S, Balal M, Gonlusen G, Inal T et al.. Effects of selective Cox-2 inhibitor, rofecoxib, alone or combination with furosemide on renal functions and renal Cox-2 expression in rats. Clinical and experimental nephrology 2010. link 60 Liu Y, Chang H, Niu L, Xue W, Zhang X, Liang Y et al.. Effects of propofol on responses of rat isolated renal arteriole to vasoactive agents. Vascular pharmacology 2009. link 61 Giorgi M, Del Carlo S, Saccomanni G, Łebkowska-Wieruszewska B, Kowalski CJ. Pharmacokinetic and urine profile of tramadol and its major metabolites following oral immediate release capsules administration in dogs. Veterinary research communications 2009. link 62 Greene TD, Joseph JV, Erturk E. Evaluation and management of post-shock wave lithotripsy pain with third-generation lithotriptors using rofecoxib. Journal of endourology 2009. link 63 Ou YC, Yang CR, Cheng CL, Li JR, Raung SL, Hung YY et al.. Indomethacin causes renal epithelial cell injury involving Mcl-1 down-regulation. Biochemical and biophysical research communications 2009. link 64 Roomi MW, Kalinovsky T, Ivanov V, Rath M, Niedzwiecki A. A nutrient mixture prevents acetaminophen hepatic and renal toxicity in ICR mice. Human & experimental toxicology 2008. link 65 Ng LE, Halliwell B, Wong KP. Nephrotoxic cell death by diclofenac and meloxicam. Biochemical and biophysical research communications 2008. link 66 Engeler DS, Schmid S, Schmid HP. The ideal analgesic treatment for acute renal colic--theory and practice. Scandinavian journal of urology and nephrology 2008. link 67 Yasmeen T, Qureshi GS, Perveen S. Adverse effects of diclofenac sodium on renal parenchyma of adult albino rats. JPMA. The Journal of the Pakistan Medical Association 2007. link 68 Mucha K, Foroncewicz B, Koziak K, Czarkowska-Paczek B, Paczek L. The effects of indomethacin on angiogenic factors mRNA expression in renal cortex of healthy rats. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2007. link 69 Reyes-Martin P, Alique M, Parra T, Hornedo JP, Lucio-Cazana J. Cyclooxygenase-independent inhibition of H2O2-induced cell death by S-ketoprofen in renal cells. Pharmacological research 2007. link 70 Harirforoosh S, Aghazadeh-Habashi A, Jamali F. Extent of renal effect of cyclo-oxygenase-2-selective inhibitors is pharmacokinetic dependent. Clinical and experimental pharmacology & physiology 2006. link 71 Alper AB, Tomlin H, Sadhwani U, Whelton A, Puschett J. Effects of the selective cyclooxygenase-2 inhibitor analgesic celecoxib on renal carbonic anhydrase enzyme activity: a randomized, controlled trial. American journal of therapeutics 2006. link 72 Lai M, Huang YC, Yao PC. Tissue necrosis after intramuscular administration of diclofenac: report of one case. Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi 2005. link 73 Lorz C, Justo P, Sanz AB, Egido J, Ortíz A. Role of Bcl-xL in paracetamol-induced tubular epithelial cell death. Kidney international 2005. link 74 Saravanan M, Bhaskar K, Narayanan NV, Maharajan G, Pillai KS. Diclofenac sodium loaded gelatin magnetic microspheres for intra-arterial administration: formulation, characterization and in vitro release studies. Bollettino chimico farmaceutico 2003. link 75 Pozarowski P, Halicka DH, Darzynkiewicz Z. NF-kappaB inhibitor sesquiterpene parthenolide induces concurrently atypical apoptosis and cell necrosis: difficulties in identification of dead cells in such cultures. Cytometry. Part A : the journal of the International Society for Analytical Cytology 2003. link 76 Lomnicka M, Karouni K, Sue M, Wessel LA, Bing RJ. Effects of nonsteroidal anti-inflammatory drugs on prostacyclin and thromboxane in the kidney. Pharmacology 2003. link 77 Jan CR, Jiann BP, Lu YC, Chang HT, Huang JK. Effect of olvanil (N-vanillyl-cis-9-octadecenoamide) on cytosolic Ca2+ increase in renal tubular cells. Life sciences 2002. link02174-4) 78 Oliver JJ, Rajapakse NW, Evans RG. Effects of indomethacin on responses of regional kidney perfusion to vasoactive agents in rabbits. Clinical and experimental pharmacology & physiology 2002. link 79 Zhou T, Yu H, Hu Q, Fang Y. Determination of codeine and its metabolite in human urine by CE with amperometric detection. Journal of pharmaceutical and biomedical analysis 2002. link00019-5) 80 Kristova V, Djibril NM, Fackovcova D, Kriska M, Kurtansky A. Comparison of vasoconstrictor responses to selected NSAIDs in rabbit renal and femoral arteries. Bratislavske lekarske listy 2002. link 81 Tritt-Goc J, Kowalczuk J. In situ, real time observation of the disintegration of paracetamol tablets in aqueous solution by magnetic resonance imaging. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2002. link00016-7) 82 Khan KN, Paulson SK, Verburg KM, Lefkowith JB, Maziasz TJ. Pharmacology of cyclooxygenase-2 inhibition in the kidney. Kidney international 2002. link 83 Sommerauer M, Ates M, Gühring H, Brune K, Amann R, Peskar BA. Ketoprofen-induced cyclooxygenase inhibition in renal medulla and platelets of rats treated with caffeine. Pharmacology 2001. link 84 Alva JP, Kotian G. Diclofenac induced renal dysfunction presenting as cardiac arrhythmia. The Journal of the Association of Physicians of India 2001. link 85 De Iuliis A, Zanatta L, Vincenti E, Galzigna L. Differences of ropivacaine and bupivacaine relevant to antiinflammatory activity, platelet aggregation and antioxidant activity in vitro. Farmaco (Societa chimica italiana : 1989) 2001. link01043-6) 86 Turull A, Piera C, Queralt J. Acute effects of the anti-inflammatory cyclooxygenase-2 selective inhibitor, flosulide, on renal plasma flow and glomerular filtration rate in rats. Inflammation 2001. link 87 Brater DC, Harris C, Redfern JS, Gertz BJ. Renal effects of COX-2-selective inhibitors. American journal of nephrology 2001. link 88 Nobre AC, Coêlho GR, Coutinho MC, Silva MM, Angelim EV, Menezes DB et al.. The role of phospholipase A(2) and cyclooxygenase in renal toxicity induced by microcystin-LR. Toxicon : official journal of the International Society on Toxinology 2001. link00193-8) 89 Lobetti RG, Joubert KE. Effect of administration of nonsteroidal anti-inflammatory drugs before surgery on renal function in clinically normal dogs. American journal of veterinary research 2000. link 90 Stichtenoth DO, Frölich JC. COX-2 and the kidneys. Current pharmaceutical design 2000. link 91 Svendsen KB, Bech JN, Sørensen TB, Pedersen EB. A comparison of the effects of etodolac and ibuprofen on renal haemodynamics, tubular function, renin, vasopressin and urinary excretion of albumin and alpha-glutathione-S-transferase in healthy subjects: a placebo-controlled cross-over study. European journal of clinical pharmacology 2000. link 92 Ko JC, Miyabiyashi T, Mandsager RE, Heaton-Jones TG, Mauragis DF. Renal effects of carprofen administered to healthy dogs anesthetized with propofol and isoflurane. Journal of the American Veterinary Medical Association 2000. link 93 Birck R, Krzossok S, Knoll T, Braun C, van Der Woude FJ, Rohmeiss P. Preferential COX-2 inhibitor, meloxicam, compromises renal perfusion in euvolemic and hypovolemic rats. Experimental nephrology 2000. link 94 Kristová V, Kriska M, Vojtko R, Kurtanský A. Effect of indomethacin and deendothelisation on vascular responses in the renal artery. Physiological research 2000. link 95 Kopp UC, Cicha MZ, Smith LA, Haeggström JZ, Samuelsson B, Hökfelt T. Cyclooxygenase-2 involved in stimulation of renal mechanosensitive neurons. Hypertension (Dallas, Tex. : 1979) 2000. link 96 Rossat J, Maillard M, Nussberger J, Brunner HR, Burnier M. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Clinical pharmacology and therapeutics 1999. link70056-1) 97 Gohel MC, Amin AF. Formulation design and optimization of modified-release microspheres of diclofenac sodium. Drug development and industrial pharmacy 1999. link 98 Brough RJ, Lancashire MJ, Prince JR, Rose MR, Prescott MC, Payne SR et al.. The effect of diclofenac (voltarol) and pethidine on ureteric peristalsis and the isotope renogram. European journal of nuclear medicine 1998. link 99 Haas M, Moolenaar F, Meijer DK, de Jong PE, de Zeeuw D. Renal targeting of a non-steroidal anti-inflammatory drug: effects on renal prostaglandin synthesis in the rat. Clinical science (London, England : 1979) 1998. link 100 Pigoso AA, Uyemura SA, Santos AC, Rodrigues T, Mingatto FE, Curti C. Influence of nonsteroidal anti-inflammatory drugs on calcium efflux in isolated rat renal cortex mitochondria and aspects of the mechanisms involved. The international journal of biochemistry & cell biology 1998. link00030-2)

    Original source

    1. [1]
      Clinical Efficacy of Intravenous Papaverine plus Ketorolac in the Emergency Treatment of Renal Colic: A Randomized, Double-blind Clinical Trial.Mozafari J, Khavanin A, Delirrooyfard A, Pirouzi M, Asmarian N Iranian journal of medical sciences (2024)
    2. [2]
      Cutaneous adverse drug reaction in a dog following firocoxib treatment.Geum M, Ko HY, Na YJ, Kim HJ Veterinary medicine and science (2021)
    3. [3]
    4. [4]
      NSAIDs Alter Phosphorylated Forms of AQP2 in the Inner Medullary Tip.Ren H, Yang B, Molina PA, Sands JM, Klein JD PloS one (2015)
    5. [5]
      Eicosanoid post-mortem induction in kidney tissue is prevented by microwave irradiation.Brose SA, Golovko MY Prostaglandins, leukotrienes, and essential fatty acids (2013)
    6. [6]
      Physiologic and pathophysiologic roles of cyclooxygenase-2 in the kidney.Harris RC Transactions of the American Clinical and Climatological Association (2013)
    7. [7]
      Augmented cyclooxygenase-2 effects on renal function during varying states of angiotensin II.Green T, Rodriguez J, Navar LG American journal of physiology. Renal physiology (2010)
    8. [8]
    9. [9]
      The effect of acetylsalicylic acid on renal function in the Pekin duck.Gray DA, Langrieger N, Reschmaier J, Simon E British journal of pharmacology (1984)
    10. [10]
      Design and structural optimization of lappaconitine derivatives as Nav1.7 inhibitors with improved analgesic efficacy and reduced lethality in mice.Wang L, Zou J, Ma X, Zhang X, Zhang Y, Xu Z et al. European journal of medicinal chemistry (2026)
    11. [11]
      NICOLAU SYNDROME: CUTANEOUS NECROSIS FOLLOWING DICLOFENAC INTRAMUSCULAR INJECTION.Bhuyyar N, Khombare B, Panicker A, Teli S, Shalavadi M, Choudhari K Georgian medical news (2025)
    12. [12]
      Effect of meloxicam or robenacoxib administration timing on renal function and postoperative analgesia in cats undergoing ovariohysterectomy: A randomized, blinded, controlled clinical trial.Krekis A, King JN, D'Arcy-Howard D, Stapleton N, Elliott J, Pelligand L Journal of veterinary pharmacology and therapeutics (2024)
    13. [13]
      Comparison of acetaminophen, ketamine, or ketorolac versus morphine in the treatment of acute renal colic: A network meta-analysis.Alghamdi YA, Morya RE, Bahathiq DM, Bokhari AF, Alaboud AK, Abdulhamid AS et al. The American journal of emergency medicine (2023)
    14. [14]
      Analgesic Effects and Adverse Reactions of Lidocaine for Patient-Controlled Intravenous Analgesia on Patients Undergoing Open Hepatectomy: A Retrospective Analysis.Liu F, Xiong LL, Li TT, Chen YJ, Ma W, Li QJ et al. Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses (2023)
    15. [15]
      Dexamethasone and ketorolac compare with ketorolac alone in acute renal colic: A randomized clinical trial.Razi A, Farrokhi E, Lotfabadi P, Hosseini SS, Saadati H, Haghighi R et al. The American journal of emergency medicine (2022)
    16. [16]
      NSAIDs and Renal Impairment: Deprescribing Chronic NSAID use in General Practice.O'Mahony L, Duffy E, Mc Ginnity M, Balmer F, Duffy I Irish medical journal (2021)
    17. [17]
    18. [18]
      PHARMACOKINETIC, PHARMACODYNAMIC, AND TOXICOLOGY STUDY OF ROBENACOXIB IN RAINBOW TROUT (Raulic J, Beaudry F, Beauchamp G, Jalenques M, Summa N, Lair S et al. Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians (2021)
    19. [19]
      SKOPE-Study of Ketorolac vs Opioid for Pain after Endoscopy: A Double-Blinded Randomized Control Trial in Patients Undergoing Ureteroscopy.Fedrigon D, Faris A, Kachroo N, Jain R, Elia M, Wilkins L et al. The Journal of urology (2021)
    20. [20]
      Comparison of intravenous ketorolac at three doses for treating renal colic in the emergency department: A noninferiority randomized controlled trial.Eidinejad L, Bahreini M, Ahmadi A, Yazdchi M, Thiruganasambandamoorthy V, Mirfazaelian H Academic emergency medicine : official journal of the Society for Academic Emergency Medicine (2021)
    21. [21]
      Gallic Acid Exerts Nephroprotective, Anti-Oxidative Stress, and Anti-Inflammatory Effects Against Diclofenac-Induced Renal Injury in Malerats.Moradi A, Abolfathi M, Javadian M, Heidarian E, Roshanmehr H, Khaledi M et al. Archives of medical research (2021)
    22. [22]
      Concomitant tacrolimus and ketorolac therapy in pediatric liver transplant recipients: Teaching old dogma new tricks.Chen J, Salerno D, Breslin N, Chowdhury T, Lobritto S, Martinez M et al. Clinical transplantation (2021)
    23. [23]
    24. [24]
    25. [25]
      Effect of tadalafil on reduction of necrosis in the ischemic zone in a rat comb burn model.Singer AJ, Towery H, McClain SA Burns : journal of the International Society for Burn Injuries (2018)
    26. [26]
    27. [27]
    28. [28]
      Nephrotoxicity in Rats Exposed to Paracetamol: The Protective Role of Moralbosteroid, a Steroidal Glycoside.Gupta G, Chellappan DK, Kikuchi IS, Pinto TJA, Pabreja K, Agrawal M et al. Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer (2017)
    29. [29]
      Diclofenac affects kidney histology in the three-spined stickleback (Gasterosteus aculeatus) at low μg/L concentrations.Näslund J, Fick J, Asker N, Ekman E, Larsson DGJ, Norrgren L Aquatic toxicology (Amsterdam, Netherlands) (2017)
    30. [30]
      Polymer based microspheres of aceclofenac as sustained release parenterals for prolonged anti-inflammatory effect.Kaur M, Sharma S, Sinha VR Materials science & engineering. C, Materials for biological applications (2017)
    31. [31]
    32. [32]
      Effects of thienorphine on the contraction of isolated ureter and bladder of guinea pigs.Zhou P, Li Y, Yong Z, Yan H, Su R, Gong Z European journal of pharmacology (2016)
    33. [33]
    34. [34]
      Desmopressin as an adjuvant to opioids or NSAIDs in treatment of renal colic: a nationwide register-based study.Juul KV, Schroeder MK, Rittig S, Nørgaard JP Pharmacoepidemiology and drug safety (2015)
    35. [35]
      Indomethacin induces endoplasmic reticulum stress, but not apoptosis, in the rat kidney.Nagappan AS, Varghese J, James JV, Jacob M European journal of pharmacology (2015)
    36. [36]
      Effect of the CYP2D6 gene polymorphism on postoperative analgesia of tramadol in Han nationality nephrectomy patients.Dong H, Lu SJ, Zhang R, Liu DD, Zhang YZ, Song CY European journal of clinical pharmacology (2015)
    37. [37]
    38. [38]
    39. [39]
      Naproxen-induced Ca2+ movement and death in MDCK canine renal tubular cells.Cheng HH, Chou CT, Sun TK, Liang WZ, Cheng JS, Chang HT et al. Human & experimental toxicology (2015)
    40. [40]
      Effects of meloxicam and phenylbutazone on renal responses to furosemide, dobutamine, and exercise in horses.Raidal SL, Hughes KJ, Charman AL, Nielsen SG, Phillips JK, Noble GK American journal of veterinary research (2014)
    41. [41]
      Comparison of the analgesic efficacy of dexketoprofen trometamol and meperidine HCl in the relief of renal colic.Ay MO, Sebe A, Kozaci N, Satar S, Acikalin A, Gulen M et al. American journal of therapeutics (2014)
    42. [42]
    43. [43]
      Nephrotic syndrome and acute tubular necrosis due to meloxicam use.Vega J, Goecke H, Méndez GP, Guarda FJ Renal failure (2012)
    44. [44]
      Renal effects of carprofen and etodolac in euvolemic and volume-depleted dogs.Surdyk KK, Sloan DL, Brown SA American journal of veterinary research (2012)
    45. [45]
    46. [46]
      Effect of selective and non-selective cyclooxygenase inhibitors on doxorubicin-induced cardiotoxicity and nephrotoxicity in rats.Ibrahim MA, Morsy MA, Hafez HM, Gomaa WM, Abdelrahman AM Toxicology mechanisms and methods (2012)
    47. [47]
      Treatment of loin pain suspected to be renal colic with papaverine hydrochloride: a prospective double-blind randomised study.Asgari SA, Asli MM, Madani AH, Maghsoudi PA, Ghanaei MM, Shakiba M et al. BJU international (2012)
    48. [48]
      Intramuscular drotaverine and diclofenac in acute renal colic: a comparative study of analgesic efficacy and safety.Dash A, Maiti R, Akantappa Bandakkanavar TK, Arora P Pain medicine (Malden, Mass.) (2012)
    49. [49]
    50. [50]
      Intravenous paracetamol in patients with renal colic.Morgan S Emergency nurse : the journal of the RCN Accident and Emergency Nursing Association (2011)
    51. [51]
    52. [52]
      Subunits Rip1p and Cox9p of the respiratory chain contribute to diclofenac-induced mitochondrial dysfunction.van Leeuwen JS, Orij R, Luttik MAH, Smits GJ, Vermeulen NPE, Vos JC Microbiology (Reading, England) (2011)
    53. [53]
      Paracetamol vs piroxicam to relieve pain in renal colic. Results of a randomized controlled trial.Grissa MH, Claessens YE, Bouida W, Boubaker H, Boudhib L, Kerkeni W et al. The American journal of emergency medicine (2011)
    54. [54]
    55. [55]
    56. [56]
      Nonsteroidal anti-inflammatory drug-associated renal papillary necrosis in a white-tailed deer (Odocoileus virginianus).Stern AW, Ritchey JW, Hall B, Ketz-Riley CJ, Genova SG Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc (2010)
    57. [57]
      Comparison of the analgesic effects of dexketoprofen and diclofenac during shockwave lithotripsy: a randomized, double-blind clinical trial.Tokgoz H, Yurtlu S, Hanci V, Turksoy O, Erol B, Akduman B et al. Journal of endourology (2010)
    58. [58]
    59. [59]
      Effects of selective Cox-2 inhibitor, rofecoxib, alone or combination with furosemide on renal functions and renal Cox-2 expression in rats.Kose F, Besen A, Paydas S, Balal M, Gonlusen G, Inal T et al. Clinical and experimental nephrology (2010)
    60. [60]
      Effects of propofol on responses of rat isolated renal arteriole to vasoactive agents.Liu Y, Chang H, Niu L, Xue W, Zhang X, Liang Y et al. Vascular pharmacology (2009)
    61. [61]
      Pharmacokinetic and urine profile of tramadol and its major metabolites following oral immediate release capsules administration in dogs.Giorgi M, Del Carlo S, Saccomanni G, Łebkowska-Wieruszewska B, Kowalski CJ Veterinary research communications (2009)
    62. [62]
    63. [63]
      Indomethacin causes renal epithelial cell injury involving Mcl-1 down-regulation.Ou YC, Yang CR, Cheng CL, Li JR, Raung SL, Hung YY et al. Biochemical and biophysical research communications (2009)
    64. [64]
      A nutrient mixture prevents acetaminophen hepatic and renal toxicity in ICR mice.Roomi MW, Kalinovsky T, Ivanov V, Rath M, Niedzwiecki A Human & experimental toxicology (2008)
    65. [65]
      Nephrotoxic cell death by diclofenac and meloxicam.Ng LE, Halliwell B, Wong KP Biochemical and biophysical research communications (2008)
    66. [66]
      The ideal analgesic treatment for acute renal colic--theory and practice.Engeler DS, Schmid S, Schmid HP Scandinavian journal of urology and nephrology (2008)
    67. [67]
      Adverse effects of diclofenac sodium on renal parenchyma of adult albino rats.Yasmeen T, Qureshi GS, Perveen S JPMA. The Journal of the Pakistan Medical Association (2007)
    68. [68]
      The effects of indomethacin on angiogenic factors mRNA expression in renal cortex of healthy rats.Mucha K, Foroncewicz B, Koziak K, Czarkowska-Paczek B, Paczek L Journal of physiology and pharmacology : an official journal of the Polish Physiological Society (2007)
    69. [69]
      Cyclooxygenase-independent inhibition of H2O2-induced cell death by S-ketoprofen in renal cells.Reyes-Martin P, Alique M, Parra T, Hornedo JP, Lucio-Cazana J Pharmacological research (2007)
    70. [70]
      Extent of renal effect of cyclo-oxygenase-2-selective inhibitors is pharmacokinetic dependent.Harirforoosh S, Aghazadeh-Habashi A, Jamali F Clinical and experimental pharmacology & physiology (2006)
    71. [71]
    72. [72]
      Tissue necrosis after intramuscular administration of diclofenac: report of one case.Lai M, Huang YC, Yao PC Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi (2005)
    73. [73]
      Role of Bcl-xL in paracetamol-induced tubular epithelial cell death.Lorz C, Justo P, Sanz AB, Egido J, Ortíz A Kidney international (2005)
    74. [74]
      Diclofenac sodium loaded gelatin magnetic microspheres for intra-arterial administration: formulation, characterization and in vitro release studies.Saravanan M, Bhaskar K, Narayanan NV, Maharajan G, Pillai KS Bollettino chimico farmaceutico (2003)
    75. [75]
      NF-kappaB inhibitor sesquiterpene parthenolide induces concurrently atypical apoptosis and cell necrosis: difficulties in identification of dead cells in such cultures.Pozarowski P, Halicka DH, Darzynkiewicz Z Cytometry. Part A : the journal of the International Society for Analytical Cytology (2003)
    76. [76]
      Effects of nonsteroidal anti-inflammatory drugs on prostacyclin and thromboxane in the kidney.Lomnicka M, Karouni K, Sue M, Wessel LA, Bing RJ Pharmacology (2003)
    77. [77]
      Effect of olvanil (N-vanillyl-cis-9-octadecenoamide) on cytosolic Ca2+ increase in renal tubular cells.Jan CR, Jiann BP, Lu YC, Chang HT, Huang JK Life sciences (2002)
    78. [78]
      Effects of indomethacin on responses of regional kidney perfusion to vasoactive agents in rabbits.Oliver JJ, Rajapakse NW, Evans RG Clinical and experimental pharmacology & physiology (2002)
    79. [79]
      Determination of codeine and its metabolite in human urine by CE with amperometric detection.Zhou T, Yu H, Hu Q, Fang Y Journal of pharmaceutical and biomedical analysis (2002)
    80. [80]
      Comparison of vasoconstrictor responses to selected NSAIDs in rabbit renal and femoral arteries.Kristova V, Djibril NM, Fackovcova D, Kriska M, Kurtansky A Bratislavske lekarske listy (2002)
    81. [81]
      In situ, real time observation of the disintegration of paracetamol tablets in aqueous solution by magnetic resonance imaging.Tritt-Goc J, Kowalczuk J European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences (2002)
    82. [82]
      Pharmacology of cyclooxygenase-2 inhibition in the kidney.Khan KN, Paulson SK, Verburg KM, Lefkowith JB, Maziasz TJ Kidney international (2002)
    83. [83]
      Ketoprofen-induced cyclooxygenase inhibition in renal medulla and platelets of rats treated with caffeine.Sommerauer M, Ates M, Gühring H, Brune K, Amann R, Peskar BA Pharmacology (2001)
    84. [84]
      Diclofenac induced renal dysfunction presenting as cardiac arrhythmia.Alva JP, Kotian G The Journal of the Association of Physicians of India (2001)
    85. [85]
      Differences of ropivacaine and bupivacaine relevant to antiinflammatory activity, platelet aggregation and antioxidant activity in vitro.De Iuliis A, Zanatta L, Vincenti E, Galzigna L Farmaco (Societa chimica italiana : 1989) (2001)
    86. [86]
    87. [87]
      Renal effects of COX-2-selective inhibitors.Brater DC, Harris C, Redfern JS, Gertz BJ American journal of nephrology (2001)
    88. [88]
      The role of phospholipase A(2) and cyclooxygenase in renal toxicity induced by microcystin-LR.Nobre AC, Coêlho GR, Coutinho MC, Silva MM, Angelim EV, Menezes DB et al. Toxicon : official journal of the International Society on Toxinology (2001)
    89. [89]
    90. [90]
      COX-2 and the kidneys.Stichtenoth DO, Frölich JC Current pharmaceutical design (2000)
    91. [91]
    92. [92]
      Renal effects of carprofen administered to healthy dogs anesthetized with propofol and isoflurane.Ko JC, Miyabiyashi T, Mandsager RE, Heaton-Jones TG, Mauragis DF Journal of the American Veterinary Medical Association (2000)
    93. [93]
      Preferential COX-2 inhibitor, meloxicam, compromises renal perfusion in euvolemic and hypovolemic rats.Birck R, Krzossok S, Knoll T, Braun C, van Der Woude FJ, Rohmeiss P Experimental nephrology (2000)
    94. [94]
      Effect of indomethacin and deendothelisation on vascular responses in the renal artery.Kristová V, Kriska M, Vojtko R, Kurtanský A Physiological research (2000)
    95. [95]
      Cyclooxygenase-2 involved in stimulation of renal mechanosensitive neurons.Kopp UC, Cicha MZ, Smith LA, Haeggström JZ, Samuelsson B, Hökfelt T Hypertension (Dallas, Tex. : 1979) (2000)
    96. [96]
      Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects.Rossat J, Maillard M, Nussberger J, Brunner HR, Burnier M Clinical pharmacology and therapeutics (1999)
    97. [97]
      Formulation design and optimization of modified-release microspheres of diclofenac sodium.Gohel MC, Amin AF Drug development and industrial pharmacy (1999)
    98. [98]
      The effect of diclofenac (voltarol) and pethidine on ureteric peristalsis and the isotope renogram.Brough RJ, Lancashire MJ, Prince JR, Rose MR, Prescott MC, Payne SR et al. European journal of nuclear medicine (1998)
    99. [99]
      Renal targeting of a non-steroidal anti-inflammatory drug: effects on renal prostaglandin synthesis in the rat.Haas M, Moolenaar F, Meijer DK, de Jong PE, de Zeeuw D Clinical science (London, England : 1979) (1998)
    100. [100]
      Influence of nonsteroidal anti-inflammatory drugs on calcium efflux in isolated rat renal cortex mitochondria and aspects of the mechanisms involved.Pigoso AA, Uyemura SA, Santos AC, Rodrigues T, Mingatto FE, Curti C The international journal of biochemistry & cell biology (1998)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG